The Renal Standing Committee oversees the consensus based entity's portfolio of renal measures, which includes measures for hemodialysis, standardized mortality and transfusion ratios, phosphorus concentration, hypercalcemia, pediatric hemodialysis, Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker therapy, optimal end stage renal disease starts, and bloodstream infections in hemodialysis patients.
Renal
Renal
Measures
Project
Measures
Final Reports
Media
Events
Events
Upcoming Events
Events
Archived Events
Events
Materials
Materials
Materials
| Material File | Material Type | Cycle |
|---|---|---|
| Fall-2022-Renal-Post-Comment-Slides-508.pdf | Presentation slides | Fall 2022 |
| Renal-Fall-2022-Final-Project-Report.pdf | Final Report | Fall 2022 |
| Fall-2022-Renal-Post-Comment-Meeting-Summary.pdf | Meeting summary | Fall 2022 |
| Post-Comment-Developer-Responses-Renal-Fall-2022.xlsx | Developer responses to comments | Fall 2022 |
| Fall-2022-Renal-Post-Comment-Agenda-508.pdf | Agenda | Fall 2022 |
| Fall-2022-Renal-Post-Comment-Memo-508.pdf | Memo | Fall 2022 |